The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1910237

No of Pages : 80

Ask Your Query

Synopsis

The global Infectious Diseases In Vitro Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infectious Diseases In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases In Vitro Diagnostics.

Report Scope

The Infectious Diseases In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Diseases In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Diseases In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • BD
  • Abbott
  • Alere
  • Quidel
  • F. Hoffmann-La Roche
  • Orasure Technologies
  • Cepheid
  • Hologic
  • Qiagen
  • Bio-Rad Laboratories
  • Siemens Healthcare

Segment by Type

  • MRSA
  • Streptococcus
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • HIV
  • Hepatitis C
  • Others

Segment by Application

  • Immunochemistry
  • Molecular Diagnostics
  • Microbiology
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2019-2030)
2.2 Infectious Diseases In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases In Vitro Diagnostics Revenue
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2023
3.5 Infectious Diseases In Vitro Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Diseases In Vitro Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.1.5 BD Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Alere
11.3.1 Alere Company Detail
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.3.5 Alere Recent Development
11.4 Quidel
11.4.1 Quidel Company Detail
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.4.5 Quidel Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Detail
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.6.5 Orasure Technologies Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.9.5 Qiagen Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Detail
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.11.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock